APA (7th ed.) Citation

Nielsen, B., Olsen, M., Mathiesen, I., Pressler, T., Jensen-Fangel, S., Ritz, C., . . . Faurholt-Jepsen, D. (2022). 6 Decline in HbA1c during the first year on elexacaftor/tezacaftor/ivacaftor in the Danish cystic fibrosis population. Journal of Cystic Fibrosis, 21, S4. https://doi.org/10.1016/S1569-1993(22)00697-X

Chicago Style (17th ed.) Citation

Nielsen, B., M. Olsen, I. Mathiesen, T. Pressler, S. Jensen-Fangel, C. Ritz, T. Almdal, and D. Faurholt-Jepsen. "6 Decline in HbA1c During the First Year on Elexacaftor/tezacaftor/ivacaftor in the Danish Cystic Fibrosis Population." Journal of Cystic Fibrosis 21 (2022): S4. https://doi.org/10.1016/S1569-1993(22)00697-X.

MLA (9th ed.) Citation

Nielsen, B., et al. "6 Decline in HbA1c During the First Year on Elexacaftor/tezacaftor/ivacaftor in the Danish Cystic Fibrosis Population." Journal of Cystic Fibrosis, vol. 21, 2022, p. S4, https://doi.org/10.1016/S1569-1993(22)00697-X.